Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma (Q80030411)
Jump to navigation
Jump to search
scientific article published on 12 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma |
scientific article published on 12 March 2007 |
Statements
Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma (English)
Martin G Friedrich
Uwe Pichlmeier
Hartwig Schwaibold
Stefan Conrad
12 March 2007